Alternative Treatment of Polycystic Ovary Syndrome: Pre-clinical and Clinical Basis for Using Plant-based Drugs
Overview
Affiliations
The most common cause of infertility and metabolic problems among women of reproductive age is polycystic ovary syndrome (PCOS), a multifaceted disorder. It is an endocrine disorder that occurs in approximately one in seven women. Among these PCOS patients, two thirds will not ovulate on a regular basis and seek treatment for ovulation induction. The symptoms vary in their severity, namely ovulation disorders, excessive androgen levels, or polycystic ovarian morphology. All these symptoms require a therapeutic approach. Many drugs are used to eradicate PCOS symptoms, like metformin, clomiphene citrate, spironolactone, and pioglitazone. Long-term treatment is required to achieve the desired outcome, which is often accompanied by significant adverse reactions. Some herbs and phytochemicals are equally effective for treating PCOS and produce minimal side effects. Recently, herbal products are gaining popularity due to their wide biological activities, safety, availability, and efficacy. The present review covers aetiology, current treatment, pathophysiology, and detailed pre-clinical and clinical studies on plants and phytochemicals that are proven to be useful for the treatment of symptoms associated with PCOS.
Yuan J, Li Z, Yu Y, Wang X, Zhao Y Front Nutr. 2025; 12:1520695.
PMID: 40008316 PMC: 11850276. DOI: 10.3389/fnut.2025.1520695.
Zhao Y, Jiang L, Li N, Cao J, Pi J Reprod Sci. 2025; .
PMID: 39881036 DOI: 10.1007/s43032-025-01788-9.
Higher oxidative balance score is associated with lower female infertility: a cross-sectional study.
Lei X, Liu X, Yu C, Xia L, Zhou L, Yao C Front Nutr. 2024; 11:1484756.
PMID: 39703331 PMC: 11658776. DOI: 10.3389/fnut.2024.1484756.
Sirotkin A, Harrath A Biomedicines. 2024; 12(10).
PMID: 39457717 PMC: 11504338. DOI: 10.3390/biomedicines12102405.
Zhang J, Arshad K, Siddique R, Xu H, Alshammari A, Albekairi N Heliyon. 2024; 10(14):e34298.
PMID: 39108850 PMC: 11301150. DOI: 10.1016/j.heliyon.2024.e34298.